Trial Profile

A Single Arm Clinical Evaluation of Safety and Efficacy of the Medtronic Resolute Onyx Zotarolimus-Eluting Coronary Stent System in the Treatment of Subjects Eligible for Percutaneous Transluminal Coronary Angioplasty (PTCA) in China

Status: Active, no longer recruiting

Phase of Trial: Phase IV

Latest Information Update: 18 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Oct 2021 Planned End Date changed from 24 Dec 2024 to 2 Oct 2025.
22 Oct 2020 Planned End Date changed from 30 Sep 2024 to 24 Dec 2024.
22 Oct 2020 Planned primary completion date changed from 30 Sep 2020 to 31 Mar 2021.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com